- Home
- CUE vs MOB Comparison
CUE vs MOB Comparison
Compare CUE & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | MOB |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 84.0M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CUE | MOB |
|---|---|---|
| Price | $0.51 | $6.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 363.2K | 323.1K |
| Earning Date | 11-12-2025 | 08-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,100,000.00 | $2,826,361.00 |
| Revenue This Year | $36.58 | $142.38 |
| Revenue Next Year | $32.10 | $99.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $1.31 |
| 52 Week High | $1.75 | $11.02 |
Technical Indicators
Market Signals| Indicator | CUE | MOB |
|---|---|---|
| Relative Strength Index (RSI) | 31.28 | 49.71 |
| Support Level | $0.55 | $5.88 |
| Resistance Level | $0.66 | $8.26 |
| Average True Range (ATR) | 0.05 | 0.87 |
| MACD | -0.00 | 0.18 |
| Stochastic Oscillator | 7.88 | 51.55 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.